ArticleScientific reports2025
The efficacy of selected Ghanaian herbal antimalarials against laboratory strains and clinical isolates of Plasmodium falciparum.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Public Health Perspectives on IntegratingTropical medicine and infectious disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The recurrent emergence of drug-resistant Plasmodium parasites threatens malaria control and elimination strategies. In Ghana, there is a growing traditional medicine (TM) sector to support health delivery. In particular, the popularity of these alternative herbal malaria treatments is rapidly growing due to easy access, low cost, and perceived benefits. Some of these herbal malaria medicines are indicated to contain compounds that are in the same chemical classes as standard ACT partner drugs (e.g., quinolines). Thus, this study sought to evaluate the efficacy of selected antimalarial herbal drugs against Plasmodium falciparum parasites. In the study, twenty commercially available liquid formulations of antimalarial herbal medicines were obtained from drug stores and pharmacies within Madina, Accra, Ghana. The formulations were lyophilized and reconstituted into 50 mg/ml stock solutions. Following this, in vitro growth inhibition assays were used to assess the anti-plasmodial activity of these formulations against five laboratory strains and two clinical isolates of P. falciparum. The data from this study shows that of the 20 herbal products tested, 30.0% (n = 6) had potent activity across the six parasite strains screened with half-maximal inhibitory concentration (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.